Ianovskiĭ O G, Zakharova L A, Vasilenko A M
Biull Eksp Biol Med. 1990 Jan;109(1):55-7.
In addition to the immunostimulating activity, bone marrow mediators, myelopeptides (MP) show the dose-dependent effect on the development of pain sensitivity in mice. When injected in nanogram amounts, MP induce hyperalgesia and 3-9 fold higher production of antibodies against SREC. When injected in milligram amounts, they exhibit hypoalgesic effect and no influence on antibody production. Immunostimulating effect in MP (mol, mass less than 1 KD, fraction 3) is accompanied with hypoalgesia. Bone marrow factors of mol. masses 40-150 KD (fraction 1) eluted at Sephadex G-25 gel-filtration before MP enhance the pain sensitivity tHreshold and show a potent immunodepressive effect. Thus the bone marrow factors are capable of exhibiting the opposite effects on the immune system in the pain control system that evidences the tight interrelation between these systems.
除免疫刺激活性外,骨髓介质——骨髓肽(MP)对小鼠痛觉敏感性的发展呈现剂量依赖性效应。以纳克量注射时,MP会诱导痛觉过敏,并使抗SREC抗体的产生增加3至9倍。以毫克量注射时,它们表现出镇痛作用,且对抗体产生没有影响。MP(摩尔质量小于1 KD,组分3)中的免疫刺激作用伴随着镇痛作用。在MP之前于Sephadex G - 25凝胶过滤中洗脱的摩尔质量为40 - 150 KD的骨髓因子(组分1)会提高痛觉敏感性阈值,并显示出强大的免疫抑制作用。因此,骨髓因子能够在疼痛控制系统中对免疫系统表现出相反的作用,这证明了这些系统之间存在紧密的相互关系。